Events

Vivet Therapeutics is pleased to announce that our CEO, Jean-Philippe Combal, will be attending the Jefferies Global Healthcare Conference in London from November 18th to

Join our CEO, @Jean-Philippe Combal in the Big Apple for @Chardan’s 9th Annual Genetic Medicines Conference! The premier event will bring together groundbreaking thought leaders

Vivet Therapeutics is excited to announce two poster presentations at ESGCT 2025 in Sevilla, showcasing innovative advances in liver-directed gene therapy. Catch us on Thursday,

Vivet Therapeutics is delighted to announce its participation in the European Society of Gene & Cell Therapy (ESGCT) Annual Congress, taking place in Sevilla, on October 7–10,

 📢 @Vivet Therapeutics is heading west for The Liver Meeting in sunny ☀ San Diego, California! ⛱  Listen in as #Vivet’s Co-founder & Chief Scientific

Join our Co-Founder & Chief Executive Officer, @Jean-Philippe Combal, and @Susan Coles, General Counsel and Head of Finance at #BIOEurope2024 in Stockholm, Sweden from 4-6

📣#VivetTherapeutics is headed to the land down under!📣 Join our Co-Founder and CSO, Dr @Gloria Gonzalez-Aseguinolaza at the Australasian Gene and Cell Therapy Society (#ASGCT)

Connect with Co-Founder & CEO, @Jean-Philippe Combal & Director of Regulatory Affairs & Quality Assurance, @Annelise Brossel at the inaugural Cell & Gene Therapy Regulatory

With over 25 years of expertise in #drugdevelopment, our Head of Clinical Operations & Patient Advocacy Representative, @Sonia Valero, will join industry leaders on a

Don’t miss the opportunity to meet the @Vivet Therapeutics leadership team who will be participating in a jam-packed schedule at the event. 👂Listen in as